Anna Łabędź-Masłowska (Anna Labedz-Maslowska)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 4

Top Topics

Intensive Care Unit

Mesenchymal Stem Cells

Top Venues

FASEB journal : official publication of the Federation of American Societies for Experimental Biology

This page only lists publications with an associated author ORCID identifier.

Publications

Katarzyna Kmiotek-Wasylewska, Anna Łabędź-Masłowska, Sylwia Bobis-Wozowicz, Elzbieta Karnas, Sylwia Noga, Małgorzata Sekuła-Stryjewska, Olga Barczyk-Woźnicka, Zbigniew Madeja, Buddhadeb Dawn, Ewa K Zuba-Surma
Induced pluripotent stem cell-derived extracellular vesicles enriched with miR-126 induce proangiogenic properties and promote repair of ischemic tissue. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 38 (2) (2024)
Katarzyna Kmiotek-Wasylewska, Anna Łabędź-Masłowska, Sylwia Bobis-Wozowicz, Elzbieta Karnas, Sylwia Noga, Małgorzata Sekuła-Stryjewska, Olga Barczyk-Woźnicka, Zbigniew Madeja, Buddhadeb Dawn, Ewa K Zuba-Surma
Induced pluripotent stem cell-derived extracellular vesicles enriched with miR-126 induce proangiogenic properties and promote repair of ischemic tissue. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 38 (2) (2024)
Katarzyna Kmiotek-Wasylewska, Anna Łabędź-Masłowska, Sylwia Bobis-Wozowicz, Elzbieta Karnas, Sylwia Noga, Małgorzata Sekuła-Stryjewska, Olga Barczyk-Woźnicka, Zbigniew Madeja, Buddhadeb Dawn, Ewa K Zuba-Surma
Induced pluripotent stem cell-derived extracellular vesicles enriched with miR-126 induce proangiogenic properties and promote repair of ischemic tissue. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 38 (2) (2024)
Anna Łabędź-Masłowska, Agnieszka Szkaradek, Tomasz Mierzwinski, Zbigniew Madeja, Ewa K Zuba-Surma
Processing and Ex Vivo Expansion of Adipose Tissue-Derived Mesenchymal Stem/Stromal Cells for the Development of an Advanced Therapy Medicinal Product for use in Humans. Cells 10 (8) (2021)